Monocyte Targeting Technology News Today

NTBL | Complete Notable Labs Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research note issued to investors on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance Shares of VBLT opened at $0.23 on Monday. The company has a market capitalization of $16.04 million, a price-to-earnings […]

StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance VBLT opened at $0.22 on Monday. The stock has a market capitalization of $15.00 million, a price-to-earnings […]

StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research note released on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Shares of Vascular Biogenics stock opened at $0.21 on Friday. The stock has a 50 day moving average of $0.18 […]

StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a report released on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Shares of VBLT opened at $0.20 on Friday. The business’s 50 day moving average is $0.17 and its 200 day moving […]

Vascular Biogenics (NASDAQ:VBLT – Get Rating) and Sigilon Therapeutics (NASDAQ:SGTX – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends. Volatility and Risk Vascular Biogenics has a beta of […]

StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research report sent to investors on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Vascular Biogenics stock opened at $0.20 on Friday. The stock has a market cap of $13.64 million, a PE […]

StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a report published on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Trading Down 4.7 % NASDAQ VBLT opened at $0.20 on Friday. Vascular Biogenics has a 12 month low of $0.10 and a 12 […]

StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research note issued to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance VBLT stock opened at $0.19 on Friday. The stock has a market cap of $13.47 million, a P/E ratio […]

StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a research report report published on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Trading Down 1.5 % Shares of NASDAQ VBLT opened at $0.17 on Thursday. The firm has a market capitalization of $12.09 […]